PL369010A1 - Sposoby, kompozycje i zestawy dotyczące chitynaz i chitynopodobnych cząsteczek oraz choroby zapalnej - Google Patents
Sposoby, kompozycje i zestawy dotyczące chitynaz i chitynopodobnych cząsteczek oraz choroby zapalnejInfo
- Publication number
- PL369010A1 PL369010A1 PL02369010A PL36901002A PL369010A1 PL 369010 A1 PL369010 A1 PL 369010A1 PL 02369010 A PL02369010 A PL 02369010A PL 36901002 A PL36901002 A PL 36901002A PL 369010 A1 PL369010 A1 PL 369010A1
- Authority
- PL
- Poland
- Prior art keywords
- chitinases
- chitinase
- molecules
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2442—Chitinase (3.2.1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01014—Chitinase (3.2.1.14)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30743201P | 2001-07-24 | 2001-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL369010A1 true PL369010A1 (pl) | 2005-04-18 |
Family
ID=23189747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL02369010A PL369010A1 (pl) | 2001-07-24 | 2002-07-23 | Sposoby, kompozycje i zestawy dotyczące chitynaz i chitynopodobnych cząsteczek oraz choroby zapalnej |
Country Status (13)
Country | Link |
---|---|
US (6) | US7214373B2 (pl) |
EP (1) | EP1418813A4 (pl) |
JP (1) | JP2006508014A (pl) |
KR (1) | KR20040053100A (pl) |
AU (1) | AU2002319680B2 (pl) |
BR (1) | BR0211468A (pl) |
CA (1) | CA2454342A1 (pl) |
HU (1) | HUP0400659A3 (pl) |
IL (2) | IL160000A0 (pl) |
MX (1) | MXPA04000769A (pl) |
NO (1) | NO20040330L (pl) |
PL (1) | PL369010A1 (pl) |
WO (1) | WO2003009808A2 (pl) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1488233A4 (en) * | 2001-10-09 | 2006-06-21 | Genentech Inc | NEW ACID MUDE PROTEINS AND THESE CODING POLYNUCLEOTIDES |
US20040170621A1 (en) * | 2002-08-30 | 2004-09-02 | Roodman G. David | Method of resisting osteoclast formation |
US7364846B2 (en) * | 2002-10-11 | 2008-04-29 | Molecular Devices Corporation | Gene expression profiling from FFPE samples |
WO2004092404A2 (en) * | 2003-04-11 | 2004-10-28 | Wyeth | Inhibitors of acidic mammalian chitinase as asthma therapeutics |
EP1729805A4 (en) * | 2004-02-25 | 2008-11-26 | Medimmune Inc | METHODS AND COMPOSITIONS RELATED TO CHITINASES AND CHITINASE-MOLECULARS AND MODULATION OF OSTEOCLASTS |
CA2613512A1 (en) | 2005-06-23 | 2007-01-04 | Medimmune, Inc. | Antibody formulations having optimized aggregation and fragmentation profiles |
US20070071746A1 (en) * | 2005-08-31 | 2007-03-29 | Medimmune, Inc. | C/CLP antagonists and methods of use thereof |
TW200813091A (en) | 2006-04-10 | 2008-03-16 | Amgen Fremont Inc | Targeted binding agents directed to uPAR and uses thereof |
US20090010942A1 (en) * | 2007-05-18 | 2009-01-08 | Wyeth | Novel primate chitinases and uses therefor |
JP2011510308A (ja) * | 2008-01-23 | 2011-03-31 | リグスホスピタル | バイオマーカーykl−40のレベルの測定により見出される生存予後に基く心血管疾患を患う個体の分類 |
CA2740028A1 (en) | 2008-01-23 | 2009-07-30 | Herlev Hospital | Ykl-40 as a general marker for non-specific disease |
WO2010012107A1 (en) * | 2008-08-01 | 2010-02-04 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
AU2009285550B2 (en) * | 2008-08-28 | 2015-06-18 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2813848A3 (en) * | 2008-08-29 | 2015-03-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US8580520B2 (en) | 2008-09-15 | 2013-11-12 | Herlev Hospital | YKL-40 as a marker for gastrointestinal cancers |
CN102246035B (zh) * | 2008-10-21 | 2014-10-22 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
EP2347260A4 (en) * | 2008-10-21 | 2012-09-26 | Astute Medical Inc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE |
AU2009313189B2 (en) | 2008-11-10 | 2014-10-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US20110229915A1 (en) * | 2008-11-22 | 2011-09-22 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US7851616B2 (en) * | 2008-12-04 | 2010-12-14 | Mingchi University Of Technology | Development of asthma therapy with rAAV-mediated AMCase shRNA |
US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN102576011B (zh) | 2009-08-07 | 2014-09-17 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的组合物和方法 |
CN102725635B (zh) | 2009-11-07 | 2015-05-20 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
CA2784889C (en) | 2009-12-20 | 2018-06-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
DK2666872T3 (en) | 2010-02-05 | 2016-07-25 | Astute Medical Inc | Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency |
NZ705411A (en) | 2010-02-26 | 2016-06-24 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
AU2011269775B2 (en) | 2010-06-23 | 2015-01-15 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
IN2012MN02812A (pl) | 2010-06-23 | 2015-05-22 | Astute Medical Inc | |
AU2011349021B2 (en) | 2010-12-23 | 2016-12-22 | Alectos Therapeutics, Inc. | Selective glycosidase inhibitors and uses thereof |
WO2012129651A1 (en) | 2011-03-31 | 2012-10-04 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
US9701693B2 (en) | 2011-06-27 | 2017-07-11 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
EP3540440B1 (en) | 2011-12-08 | 2022-09-28 | Astute Medical, Inc. | Methods and uses for evaluating renal injury and renal status |
US20150050674A1 (en) * | 2012-02-27 | 2015-02-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US9670195B2 (en) | 2012-08-31 | 2017-06-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
US9809537B2 (en) | 2012-08-31 | 2017-11-07 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
RU2672873C2 (ru) | 2012-10-31 | 2018-11-20 | Алектос Терапьютикс Инк. | Ингибиторы гликозидаз и их применения |
CN107976547B (zh) | 2013-01-17 | 2020-08-25 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
GB2521675B (en) | 2013-12-31 | 2015-11-11 | Houman Taheri Amlashi | Generating electricity |
JP6209289B2 (ja) * | 2014-10-22 | 2017-10-04 | サントリーホールディングス株式会社 | 環状ジペプチドを有効成分とする皮膚保湿機能改善剤 |
WO2016100912A1 (en) | 2014-12-18 | 2016-06-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
JPWO2016136991A1 (ja) * | 2015-02-27 | 2017-12-07 | 味の素株式会社 | 唾液中マーカータンパク質を用いた低栄養状態の判定方法、及びそれに使用する診断薬 |
EP3465201A4 (en) | 2016-06-06 | 2020-08-26 | Astute Medical, Inc. | MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR |
CA3078461A1 (en) | 2017-08-17 | 2019-02-21 | Brown University | Methods and compositions relating to the treatment of fibrosis |
JP7267562B2 (ja) * | 2018-05-21 | 2023-05-02 | 学校法人東京薬科大学 | 免疫調節作用を有する単球およびその使用方法 |
CN108926708A (zh) * | 2018-07-31 | 2018-12-04 | 张家港市第人民医院 | 过敏性鼻炎小鼠模型复制方法及应用 |
US20230173038A1 (en) * | 2020-04-03 | 2023-06-08 | Standard Of Care Corporation | Aerosolized hyaluronidase and/or 4-methylumbelliferone compositions and methods of using same to treat respiratory diseases or disorders |
WO2024073612A2 (en) * | 2022-09-30 | 2024-04-04 | Cedars-Sinai Medical Center | Therapeutic nucleic acids and methods of use thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5070191A (en) | 1989-04-27 | 1991-12-03 | Ajinomoto Co., Inc. | Demethylallosamidin and a process for production thereof |
JP3063930B2 (ja) | 1991-01-31 | 2000-07-12 | 味の素株式会社 | アロサミジン化合物及びその製造法 |
AU7205894A (en) * | 1993-06-08 | 1995-01-03 | Neogenix, Inc. | Purified natural and synthetic compounds for the treatment of osteoarthritis |
US7229770B1 (en) | 1998-10-01 | 2007-06-12 | The Regents Of The University Of California | YKL-40 as a marker and prognostic indicator for cancers |
CA2164498C (en) * | 1993-07-09 | 2007-09-11 | Paul A. Price | Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
IL115744A (en) * | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
JP3634891B2 (ja) | 1995-04-06 | 2005-03-30 | 株式会社海洋バイオテクノロジー研究所 | キチナーゼ阻害物質 |
US5773259A (en) * | 1996-03-20 | 1998-06-30 | Smithkline Beecham Corporation | Tissue remodeling proteins |
US5843449A (en) * | 1996-03-25 | 1998-12-01 | Akzo Nobel N.V. | Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
EP0828752A4 (en) | 1996-03-29 | 2000-07-26 | Smithkline Beecham Corp | CHITOTRIOSIDASE |
EP0805206A3 (en) * | 1996-05-03 | 1999-09-15 | Smithkline Beecham Corporation | Human cartilage glycoprotein |
US5811535A (en) * | 1996-08-09 | 1998-09-22 | Smithkline Beecham Corporation | Human cartilege gp39-like gene |
IL122233A (en) * | 1996-12-06 | 2001-04-30 | Akzo Nobel Nv | Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them |
US6200951B1 (en) | 1998-03-12 | 2001-03-13 | Icos Corporation | Chitinase chitin-binding fragments |
US6060590A (en) * | 1998-03-31 | 2000-05-09 | The Regents Of The University Of California | Chitinase related proteins and methods of use |
KR20010071020A (ko) | 1998-07-23 | 2001-07-28 | 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 | 자가 면역 질환의 면역 요법에서 사용하기 위한 신규한펩티드 |
JP2002521344A (ja) | 1998-07-23 | 2002-07-16 | アクゾ・ノベル・エヌ・ベー | 免疫疾患におけるHCgp−39の使用 |
JP2000327575A (ja) | 1999-05-26 | 2000-11-28 | Teika Seiyaku Kk | ジケトピペラジン誘導体含有炎症疾患治療剤および新規なジケトピペラジン誘導体 |
AU1309601A (en) * | 1999-11-15 | 2001-05-30 | Takeda Chemical Industries Ltd. | Novel protein and dna thereof |
WO2002014341A1 (en) * | 2000-08-14 | 2002-02-21 | Human Genome Sciences, Inc. | 8 human secreted proteins |
EP1319184B1 (en) | 2000-08-14 | 2007-07-25 | N.V. Organon | Use of antibodies against specific mhc-peptide complexes |
DE10046267A1 (de) | 2000-09-19 | 2002-03-28 | Bayer Ag | Verwendung von Riboflavin und Flavinderivaten als Inhibitoren von Chitinasen |
US20030087414A1 (en) * | 2001-11-02 | 2003-05-08 | Aerts Johannes Maria Franciscus Gerardus | Mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases |
US20040170621A1 (en) * | 2002-08-30 | 2004-09-02 | Roodman G. David | Method of resisting osteoclast formation |
WO2006089549A1 (en) | 2005-02-28 | 2006-08-31 | Bio-Y A/S | Ykl-40 monoclonal antibodies |
-
2002
- 2002-07-23 EP EP02750284A patent/EP1418813A4/en not_active Withdrawn
- 2002-07-23 MX MXPA04000769A patent/MXPA04000769A/es unknown
- 2002-07-23 WO PCT/US2002/023516 patent/WO2003009808A2/en active Application Filing
- 2002-07-23 US US10/202,436 patent/US7214373B2/en not_active Expired - Lifetime
- 2002-07-23 IL IL16000002A patent/IL160000A0/xx unknown
- 2002-07-23 AU AU2002319680A patent/AU2002319680B2/en not_active Ceased
- 2002-07-23 PL PL02369010A patent/PL369010A1/pl not_active Application Discontinuation
- 2002-07-23 HU HU0400659A patent/HUP0400659A3/hu unknown
- 2002-07-23 BR BR0211468-2A patent/BR0211468A/pt not_active IP Right Cessation
- 2002-07-23 CA CA002454342A patent/CA2454342A1/en not_active Abandoned
- 2002-07-23 JP JP2003515201A patent/JP2006508014A/ja not_active Withdrawn
- 2002-07-23 KR KR10-2004-7001099A patent/KR20040053100A/ko not_active Application Discontinuation
-
2004
- 2004-01-22 IL IL160000A patent/IL160000A/en not_active IP Right Cessation
- 2004-01-23 NO NO20040330A patent/NO20040330L/no not_active Application Discontinuation
- 2004-11-03 US US10/980,354 patent/US20060063728A1/en not_active Abandoned
-
2008
- 2008-07-18 US US12/218,836 patent/US20090149410A1/en not_active Abandoned
- 2008-07-18 US US12/218,840 patent/US20090148539A1/en not_active Abandoned
- 2008-11-21 US US12/275,737 patent/US20090162347A1/en not_active Abandoned
-
2010
- 2010-07-12 US US12/834,650 patent/US8679503B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20090162347A1 (en) | 2009-06-25 |
US20030049261A1 (en) | 2003-03-13 |
BR0211468A (pt) | 2004-11-23 |
US20130136751A1 (en) | 2013-05-30 |
JP2006508014A (ja) | 2006-03-09 |
US7214373B2 (en) | 2007-05-08 |
CA2454342A1 (en) | 2003-02-06 |
US8679503B2 (en) | 2014-03-25 |
EP1418813A2 (en) | 2004-05-19 |
HUP0400659A3 (en) | 2005-06-28 |
WO2003009808A3 (en) | 2003-09-04 |
IL160000A0 (en) | 2004-06-20 |
AU2002319680B2 (en) | 2008-04-10 |
US20090148539A1 (en) | 2009-06-11 |
KR20040053100A (ko) | 2004-06-23 |
WO2003009808A2 (en) | 2003-02-06 |
IL160000A (en) | 2010-06-16 |
US20060063728A1 (en) | 2006-03-23 |
NO20040330L (no) | 2004-03-09 |
US20090149410A1 (en) | 2009-06-11 |
HUP0400659A2 (hu) | 2005-02-28 |
EP1418813A4 (en) | 2009-03-04 |
MXPA04000769A (es) | 2005-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400659A3 (en) | Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease | |
FI20021772A (fi) | Uudet hiilihydraattikoostumukset ja menetelmä niiden valmistamiseksi | |
EP1651053A4 (en) | COMPOSITIONS AND METHODS FOR FROZEN PASTA COMPOSITIONS READY TO BE COOKED | |
WO2006096490A3 (en) | ANTI-MAdCAM ANTIBODY COMPOSITIONS | |
EP1692318A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF LUNG CANCER | |
EP1668024A4 (en) | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INCLUDING INFLAMMATORY SUFFERING | |
GB0109763D0 (en) | Improvements in and relating to organic compositions | |
EP1667730A4 (en) | COMPOSITIONS AND METHOD FOR TREATING INFLAMMATORY LUNG DISEASE | |
DE60111430D1 (de) | Hypochlorige säure zusammensetzung und ihre verwendungen | |
FR2831433B1 (fr) | Composition topique solide | |
JP2006502186A5 (ja) | β-グルカンの使用 | |
EP1613269A4 (en) | COMPOSITIONS, METHODS AND KITS RELATING TO CLEARING HER-2 | |
EP1628993A4 (en) | METHOD AND COMPOSITIONS FOR RNA INTERFERENCE | |
GB0403534D0 (en) | Stable detergent composition and process to prepare the same | |
AU2001268232A1 (en) | Compositions, methods, and kits relating to resistin-like molecules | |
PL1966099T3 (pl) | Kompozycja, fryta, emalia oraz ceramiczne komponenty i proces w celu ich uzyskania | |
EP1409507A4 (en) | COMPOSITIONS, METHODS AND KITS RELATING TO REMODELIN | |
AU2002253889A1 (en) | Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules | |
DE60206298D1 (de) | Kombinierte heiz- und leistungseinheit für den haushalt | |
ZA200707375B (en) | Topical gel compositions | |
AU2002360531A1 (en) | Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201 | |
AU2002322515A1 (en) | Compositions, methods, and kits related to treating and diagnosing hypertension | |
EP1610757A4 (en) | PROFILING OF CONFORMATIONAL VARIANTS, ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF | |
GB0129824D0 (en) | Improvements in or relating to fixing plugs | |
FI20011630A0 (fi) | Karsintalaitteisto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |